Quinazoline based EGFR inhibitors containing a zinc binding moiety

• 收藏
• 分享

专利权人:

Changgeng Qian

发明人:

Changgeng Qian,Xiong Cai,Stephen Gould

申请号：

US12423577

公开号：

US08455506B2

申请日:

2009.04.14

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to quinazoline containing zinc-binding moiety based derivatives of Formula (I) below.These compounds have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and are useful in the treatment of EGFR-TK related diseases and disorders such as cancer. These compounds may further act as HDAC inhibitors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/